United Kingdom
# |
Name |
Net Cash Used For Investing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 5.20 B
|
March 31, 2024 | USD 11.13 | -2.11% |
|
United Kingdom |
|
2 |
USD 50.14 M
|
July 31, 2024 | USD 25.30 | -1.17% |
|
United Kingdom |
|
3 |
USD 20.90 M
|
Dec. 31, 2023 | USD 5.33 | 1.52% |
|
United Kingdom |
|
4 |
USD 14.68 M
|
Aug. 31, 2023 | USD 0.13 | 4.36% |
|
United Kingdom |
|
5 |
USD 8.30 M
|
Dec. 31, 2023 | USD 0.70 | -3.05% |
|
United Kingdom |
|
6 |
USD 3.58 M
|
Dec. 31, 2023 | USD 0.03 | -12.38% |
|
United Kingdom |
|
7 |
USD 3.57 M
|
Dec. 31, 2023 | USD 5.04 | -2.51% |
|
United Kingdom |
|
8 |
USD 624.77 K
|
Dec. 31, 2023 | USD 1.16 | -5.69% |
|
United Kingdom |
|
9 |
USD 222.35 K
|
April 30, 2024 | USD 0.12 | -0.69% |
|
United Kingdom |
|
10 |
USD 173.04 K
|
Dec. 31, 2023 | USD 0.05 | 1.59% |
|
United Kingdom |
|
11 |
USD 1.27 K
|
June 30, 2024 | USD 0.03 | 1.77% |
|
United Kingdom |
|
12 |
USD 1.26 K
|
March 31, 2024 | USD 0.09 | -2.82% |
|
United Kingdom |
|
13 |
USD 0.00
|
March 31, 2024 | USD 1.06 | -3.64% |
|
United Kingdom |
|
14 |
USD 0.00
|
Dec. 31, 2023 | USD 57.30 | 0.10% |
|
United Kingdom |
|
15 |
USD 0.00
|
Dec. 31, 2023 | USD 1.09 | -19.26% |
|
United Kingdom |
|
16 |
USD -3.10 K
|
Dec. 31, 2023 | USD 0.03 | 4.40% |
|
United Kingdom |
|
17 |
USD -19.26 K
|
June 30, 2024 | USD 0.01 | -9.39% |
|
United Kingdom |
|
18 |
USD -20.13 K
|
June 30, 2024 | USD 38.56 | 0.38% |
|
United Kingdom |
|
19 |
USD -29.11 K
|
June 30, 2024 | USD 0.25 | 0.38% |
|
United Kingdom |
|
20 |
USD -40.64 K
|
Dec. 31, 2023 | USD 4.20 | -6.92% |
|
United Kingdom |
|
21 |
USD -64.00 K
|
Dec. 31, 2023 | USD 4.31 | 3.36% |
|
United Kingdom |
|
22 |
USD -66.89 K
|
Dec. 31, 2023 | USD 0.04 | -11.51% |
|
United Kingdom |
|
23 |
USD -231.00 K
|
Dec. 31, 2023 | USD 0.05 | 0.38% |
|
United Kingdom |
|
24 |
USD -258.28 K
|
Dec. 31, 2023 | USD 0.20 | -0.86% |
|
United Kingdom |
|
25 |
USD -419.00 K
|
Dec. 31, 2023 | USD 3.01 | 2.73% |
|
United Kingdom |
|
26 |
USD -433.86 K
|
Dec. 31, 2023 | USD 0.21 | 3.52% |
|
United Kingdom |
|
27 |
USD -504.19 K
|
Sept. 30, 2024 | USD 0.16 | 4.56% |
|
United Kingdom |
|
28 |
USD -1.16 M
|
March 31, 2024 | USD 1.69 | 0.00% |
|
United Kingdom |
|
29 |
USD -1.17 M
|
Dec. 31, 2023 | USD 0.76 | 0.22% |
|
United Kingdom |
|
30 |
USD -1.52 M
|
June 30, 2024 | USD 0.07 | -16.83% |
|
United Kingdom |
|
31 |
USD -1.67 M
|
May 31, 2024 | USD 0.24 | 1.95% |
|
United Kingdom |
|
32 |
USD -1.82 M
|
Dec. 31, 2023 | USD 0.20 | -2.58% |
|
United Kingdom |
|
33 |
USD -1.90 M
|
Dec. 31, 2023 | USD 14.61 | -1.71% |
|
United Kingdom |
|
34 |
USD -2.44 M
|
March 31, 2024 | USD 0.09 | -6.74% |
|
United Kingdom |
|
35 |
USD -2.70 M
|
Dec. 31, 2023 | USD 0.16 | 0.38% |
|
United Kingdom |
|
36 |
USD -2.91 M
|
June 30, 2024 | USD 0.22 | 1.80% |
|
United Kingdom |
|
37 |
USD -2.93 M
|
Dec. 31, 2023 | USD 13.39 | 4.86% |
|
United Kingdom |
|
38 |
USD -3.09 M
|
Dec. 31, 2023 | USD 0.03 | -3.20% |
|
United Kingdom |
|
39 |
USD -3.84 M
|
Dec. 31, 2023 | USD 0.57 | 0.38% |
|
United Kingdom |
|
40 |
USD -4.31 M
|
March 31, 2024 | USD 0.80 | 0.38% |
|
United Kingdom |
|
41 |
USD -5.42 M
|
Dec. 31, 2023 | USD 32.88 | 0.83% |
|
United Kingdom |
|
42 |
USD -6.23 M
|
April 30, 2024 | USD 0.65 | -1.49% |
|
United Kingdom |
|
43 |
USD -6.59 M
|
Dec. 31, 2023 | USD 0.24 | -0.40% |
|
United Kingdom |
|
44 |
USD -7.18 M
|
Dec. 31, 2023 | USD 0.32 | 2.99% |
|
United Kingdom |
|
45 |
USD -7.47 M
|
Dec. 31, 2023 | USD 1.42 | -3.02% |
|
United Kingdom |
|
46 |
USD -10.99 M
|
Dec. 31, 2023 | USD 2.21 | 0.46% |
|
United Kingdom |
|
47 |
USD -11.08 M
|
Dec. 31, 2023 | USD 1.98 | 0.38% |
|
United Kingdom |
|
48 |
USD -11.45 M
|
Dec. 31, 2023 | USD 0.59 | 0.38% |
|
United Kingdom |
|
49 |
USD -23.28 M
|
Dec. 31, 2023 | USD 0.23 | 1.77% |
|
United Kingdom |
|
50 |
USD -40.33 M
|
Dec. 31, 2023 | USD 49.95 | -1.36% |
|
United Kingdom |
The Healthcare company in United Kingdom with the highest Net Cash Used For Investing Activities is Roivant Sciences Ltd. (NasdaqGS: ROIV) at USD 5.20 B.
The Healthcare company in United Kingdom with the lowest Net Cash Used For Investing Activities is AstraZeneca PLC (LSE: AZN.L) at USD -4.06 B.
The top 10 Healthcare companies in United Kingdom by Net Cash Used For Investing Activities are Roivant Sciences Ltd., Smiths Group plc, Silence Therapeutics plc, Oncimmune Holdings plc, Arecor Therapeutics plc, Synairgen plc, Oxford Biomedica plc, Aptorum Group Limited, Scancell Holdings plc and GENinCode plc.
The bottom 10 Healthcare companies in United Kingdom by Net Cash Used For Investing Activities are AstraZeneca PLC, GSK plc, Smith & Nephew plc, Diploma PLC, Halma plc, Hikma Pharmaceuticals PLC, ConvaTec Group Plc, Spire Healthcare Group plc, Haleon plc and Centessa Pharmaceuticals plc.